Friday - May 9, 2025
5- And 6-Azaindole Compounds for Inhibition of BCR-ABL Tyrosine Kinases
Copyright © Targeted News Service, 2023
2023-09-26
ALEXANDRIA, Virginia, Sept. 26 -- ENLIVEN INC., Boulder, Colorado has been assigned a patent (No. US 11767321 B2, initially filed Oct. 4, 2021) developed by three inventors Joseph P. Lyssikatos, Boulder, Colorado; Samuel Kintz, Boulder, Colorado; and Li Ren, Superior, Colorado, for "5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases." . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information or a free trial

Copyright Targeted News Service 2023